- Original guidelines extended testing beyond election day
- Trump official claims ‘no medical need’ for two-month period
The White House blocked new Food and Drug Administration guidelines for the release of a coronavirus vaccine that would almost certainly have ensured the vaccine would not be approved before the presidential election on 3 November.
The FDA planned to instruct that vaccine developers follow patients in trials for at least two months, to rule out safety issues before seeking emergency approval.
